Medications Updated During 2009, From Newest to Oldest, Page 30

Page 30 of 140 « First Page « … 5 10 15 20 25 … 28 29 30 31 32 … 35 40 45 50 55 … » Last Page »

Treatment Set TS332256

When the natural exposure to elevated aeroallergens produces symptoms as described under Clinical Pharmacology, specific diagnosis and therapeutic procedures are indicated. Clearly, important clues to the cause of a person’s allergic condition can…

Antigen Laboratories, Inc.2 December 2009

Treatment Set TS329678

Antigen Laboratories, Inc.2 December 2009

HYDROMORPHONE HYDROCHLORIDE

Hydromorphone hydrochloride tablets USP are indicated for the management of pain in patients where an opioid analgesic is appropriate. CONTRAINDICATIONS: Hydromorphone hydrochloride tablets are contraindicated in: patients with known…

Blenheim Pharmacal, Inc.2 December 2009

Cetirizine Hydrochloride

Cetirizine hydrochloride syrup is indicated for the relief of symptoms associated with perennial allergic rhinitis due to allergens such as dust mites, animal dander and molds in children 6 to 23 months of age. Symptoms treated effectively include…

Caraco Pharmaceutical Laboratories, Ltd.2 December 2009

Chlorpropamide

Chlorpropamide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. CONTRAINDICATIONS: Chlorpropamide tablets are…

Mylan Pharmaceuticals Inc.1 December 2009

Page 30 of 140 « First Page « … 5 10 15 20 25 … 28 29 30 31 32 … 35 40 45 50 55 … » Last Page »

FDA Medwatch

CME America Announces a Follow-Up on the Voluntary Recall of BodyGuard® Infusion System Administration Sets
Tue, 07 Jul 2020. As part of CME America's commitment to quality, following the previously announced recall (April 27, 2020) of the BodyGuard® Infusion Pump Systems, the company conducted additional flow-rate accuracy testing. This testing revealed that some…
Lupin Pharmaceuticals, Inc. Issues Voluntarily Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, 500mg and 1000mg Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity
Tue, 07 Jul 2020. Lupin Pharmaceuticals Inc. is voluntarily recalling all batches of Metformin Hydrochloride Extended-Release Tablets USP, 500mg and 1000mg to the consumer level. As part of the ongoing assessment and continuation of the dialog with the FDA,…

MedLibrary.org

Medication Sections

RSS Feeds

About

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.